Read More

What’s Going On With Candel Therapeutics Stock?

Candel Therapeutics, Inc. (NASDAQ:CADL) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. "We recently reported data from the phase 2 randomized clinical trial of CAN-2409 in borderline resectable pancreatic cancer, showing that CAN-2409, when added to standard of care, more than doubled the median overall survival obtained with standard of care alone," said Paul Peter Tak, MD, PhD, CEO of Candel.

CADL

Read More

WallStreetBets Reacts To Boeing Whistleblower: ‘Wish Me Luck’

According to a report from The New York Times, former Boeing engineer turned whistleblower, Sam Salehpour, claims the fuselage sections on 787 Dreamliners are improperly fastened together and could break apart mid-flight. Members of Reddit's r/WallStreetBets community are commenting on the whistleblower's allegations regarding safety and quality deficiencies at Boeing. 

BA

Read More

Rent The Runway Stock Soars On Mixed Q4 Results

Rent the Runway shares rose more than 36% during the regular session Wednesday and are up an additional 58.6% after-hours at $11.74 at the time of publication. "2023 was a year of significant improvements to the customer experience that we believe have set the foundation for a milestone fiscal year 2024," said Jennifer Hyman, CEO of Rent the Runway.

RENT

Read More

What’s Going On With Boeing Stock Now?

Boeing's troubles continued Tuesday as new safety concerns came to light from whistleblower and Boeing engineer, Sam Salehpour. Salehpour claims that the fuselage sections on 787 Dreamliners are improperly fastened together and could break apart mid-flight. The U.S. Senate Permanent Subcommittee on Investigations will hold a hearing next Wednesday to examine Boeing's safety culture, including Salehpour's claims.

BA

Read More

What’s Going On With Revolution Medicines Stock?

Revolution Medicines announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. The company also announced the publication of two peer-reviewed research papers in "Nature" Tuesday. The first paper highlights the discovery and preclinical characterization of RMC-7977, and the second paper highlights the systematic evaluation of RMC-7977 in a wide range of preclinical models of PDAC.

RVMD

Read More

What’s Going On With Marathon Digital And Riot Platforms Stock?

Bitcoin miners are preparing for the upcoming halving event, projected to take place on April 20. The CEOs of Riot Platforms and Marathon Digital shared insights on their strategies exclusively with Benzinga. "The Halving immediately cuts revenue in half while doubling costs for miners," Riot CEO Jason Les said. "Depending on your power cost and machine efficiency, some miners will be uneconomic and will be forced to shut off, decreasing network hash rate by at least 5% and possibly more depending on the trend for BTC prices."

MARA

Read More

What’s Going On With Beamr Imaging Stock?

Beamr Imaging shares are trading higher Tuesday after the company announced it will demonstrate a real-time video optimization application with Nvidia's Holoscan for Media. "Livestreams are being revolutionized by emerging workflows that demand greater efficiency and flexibility," said Sepi Motamedi, Senior Product Marketing Manager for Live Media Solutions at NVIDIA.

BMR